regulatory
confidence high
sentiment neutral
materiality 0.60
Genprex, Inc. (GNPX): Nasdaq/NYSE listing notice — Genprex regains Nasdaq stockholders' equity compliance; bid price issue unresolved
Genprex, Inc.
- Received Nasdaq confirmation on June 6, 2025 that it regained compliance with stockholders' equity requirement of $2.5M.
- Previously reported non-compliance with minimum bid price of $1.00 per share; compliance period ends August 6, 2025.
- Company may consider reverse stock split or other options to regain bid price compliance; delisting risk remains.